Transplantation
Journal
Overview
publication venue for
-
Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey.
104:349-356.
2020
-
Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects.
103:1392-1404.
2019
-
Biomarkers for Chronic Rejection: In Angiotensin Proteins We Trust?.
103:1082-1083.
2019
-
International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.
103:45-56.
2019
-
Predicting Liver Allograft Discard: The Discard Risk Index.
102:1520-1529.
2018
-
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
102:953-960.
2018
-
Vouchers for Future Kidney Transplants to Overcome ‘Chronological Incompatibility’ Between Living Donors and Recipients
2017
-
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in de Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
101:341-349.
2017
-
The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological Malignancies
2016
-
Early readmission after kidney transplantation: Examination of discharge-level factors.
100:1079-85.
2016
-
Design and implementation of the international genetics and translational research in transplantation network.
99:2401-12.
2015
-
Barriers to preemptive renal transplantation: A single center questionnaire study.
99:576-9.
2015
-
Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin G antibodies predictive of acute antibody-mediated rejection and kidney allograft failure.
99:1156-64.
2015
-
Prevalence of incidental findings on abdominal computed tomography angiograms on prospective renal donors.
99:1203-7.
2015
-
Gut microbial community structure and complications after kidney transplantation: a pilot study.
98:697-705.
2014
-
Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients.
98:292-9.
2014
-
Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
97:1216-24.
2014
-
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection.
97:534-40.
2014
-
CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.
98:394-401.
2014
-
Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
96:782-90.
2013
-
Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: A single-center report of 1166 kidney allograft recipients.
96:732-8.
2013
-
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): A phase 2 trial of stable renal transplant recipients.
96:191-7.
2013
-
Noninvasive prognostication of polyomavirus BK virus-associated nephropathy.
96:131-8.
2013
-
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: A 12-year experience.
95:960-5.
2013
-
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: A single-center retrospective analysis.
95:949-54.
2013
-
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: Clinical outcomes and messenger RNA profiles.
95:711-20.
2013
-
Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
95:434-41.
2013
-
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.
95:519-26.
2013
-
MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis.
94:1086-94.
2012
-
Early corticosteroid withdrawal in recipients of renal allografts: A single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.
94:837-44.
2012
-
Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
94:603-11.
2012
-
Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.
94:539-43.
2012
-
Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.
94:499-505.
2012
-
Safety of blood group a2-to-o liver transplantation: An analysis of the united network of organ sharing database.
94:526-31.
2012
-
Antithymocyte globulin induction in living donor renal transplant recipients: Final report of the TAILOR registry.
94:331-7.
2012
-
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.
93:1136-46.
2012
-
Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T Cells into alloantigen-specific and allograft protective foxp3+ regulatory T cells.
93:580-8.
2012
-
Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction.
93:54-60.
2012
-
Results of repeat renal transplantation after graft loss from BK virus nephropathy.
92:781-6.
2011
-
Effect of immunosuppression for first kidney or kidney/pancreas transplant on sensitization at the time of second transplant.
91:751-6.
2011
-
Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection.
91:27-34.
2011
-
Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.
90:1381-7.
2010
-
Hodgkin lymphoma among US solid organ transplant recipients.
90:1011-5.
2010
-
Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function.
90:709-16.
2010
-
Successful transplantation of single kidneys from pediatric donors weighing less than or equal to 10 kg into standard weight adult recipients.
90:518-22.
2010
-
Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.
90:189-97.
2010
-
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation.
89:1126-33.
2010
-
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
89:727-32.
2010
-
Impact of reduced nephron mass on cyclosporine-and/or sirolimus-induced nephrotoxicity.
88:1323-31.
2009
-
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: Results from an open-label, randomized Trial.
86:1187-95.
2008
-
Epidemiology of BK virus in renal allograft recipients: Independent risk factors for bk virus replication.
86:521-8.
2008
-
Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
86:313-20.
2008
-
Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor.
85:1833-40.
2008
-
OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ tregs.
85:1659-62.
2008
-
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus.
85:827-33.
2008
-
Ipsilateral placement in double-kidney transplantation.
84:929-31.
2007
-
The effect of etanercept on cardiac transplant recipients: A study of TNFα antagonism and cardiac allograft hypertrophy.
84:480-3.
2007
-
BK virus-associated nephropathy in sirolimus-treated renal transplant patients: Incidence, course, and clinical outcomes.
84:83-8.
2007
-
Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts.
83:1643-7.
2007
-
Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
83:539-45.
2007
-
Changes in coronary arterial dimensions early after cardiac transplantation.
83:700-5.
2007
-
Impaired arterial compliance and aerobic endurance in kidney transplant recipients.
82:920-3.
2006
-
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
82:398-405.
2006
-
Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft.
82:567-9.
2006
-
Clinical utility of histological features of polyomavirus allograft nephropathy.
82:196-204.
2006
-
Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
81:1101-5.
2006
-
Heart allograft protection with low-dose carbon monoxide inhalation: Effects on inflammatory mediators and alloreactive T-cell responses.
81:220-30.
2006
-
Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts.
80:1535-40.
2005
-
Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality.
80:1003-11.
2005
-
Fulminant hepatic failure from primary hepatic lymphoma: Successful treatment with orthotopic liver transplantation and chemotherapy.
80:993-6.
2005
-
Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients.
80:749-58.
2005
-
Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets.
79:842-5.
2005
-
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporin-induced nephrotoxicity.
79:401-8.
2005
-
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registry.
78:1676-82.
2004
-
A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: A single-center experience.
78:1560-3.
2004
-
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection.
77:1866-75.
2004
-
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation.
77:1228-35.
2004
-
Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages.
77:1281-7.
2004
-
Preservation of human pancreatic islet in vivo function after 6-month culture in serum-free media.
77:1147-54.
2004
-
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: Three-year results.
77:1269-75.
2004
-
Pulsatile machine perfusion with vasosol solution improves early graft function after cadaveric renal transplantation (Retraction in: Transplantation (2005) 79:12 (1774)).
77:1264-8.
2004
-
Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: Macrophage scavenger receptor regulation.
77:497-504.
2004
-
Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.
77:462-6.
2004
-
Right laparoscopic live donor nephrectomy: A single institution experience.
77:437-40.
2004
-
Toll-like receptor-4 and allograft responses.
77:475-7.
2004
-
Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation.
77:309-11.
2004
-
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
76:994-9.
2003
-
Successful transplantation of donor organs from a hemlock poisoning victim.
76:874-6.
2003
-
Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression.
76:597-602.
2003
-
Adenovirus infection in pediatric small bowel transplantation recipients.
76:183-9.
2003
-
Liver transplantation for acute Budd-Chiari syndrome in identical twin sisters with factor V Leiden mutation.
76:195-8.
2003
-
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation.
75:1977-83.
2003
-
Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection.
75:1752-4.
2003
-
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts.
75:1565-70.
2003
-
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts.
75:1307-12.
2003
-
Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
75:1301-6.
2003
-
Posttransplant administration of allochimeric major histocompatibility complex class-I molecules induces true transplantation tolerance.
75:550-3.
2003
-
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: Results with kidney retransplantation.
75:490-4.
2003
-
MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature.
75:225-8.
2003
-
Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic BCL-2.
74:1489-96.
2002
-
Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: A hypothesis.
74:1273-80.
2002
-
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine.
74:987-94.
2002
-
Islet filtration: A simple and rapid new purification procedure that avoids Ficoll and improves islet mass and function.
74:877-9.
2002
-
Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation.
74:701-7.
2002
-
Enforced c-Rel deficiency prolongs survival of islet allografts.
74:291-8.
2002
-
Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency.
74:406-7.
2002
-
Investigation of promoter polymorphisms in the tumor necrosis factor-α and interleukin-10 genes in liver transplant patients.
73:1886-91.
2002
-
Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy.
73:1565-72.
2002
-
Early graft function after pediatric liver transplantation: Comparison between in situ split liver grafts and living-related liver grafts.
72:1795-802.
2001
-
Improved in vivo pancreatic islet function after prolonged in vitro islet culture.
72:1730-6.
2001
-
Lung transplantation after allogeneic marrow transplantation in pediatric patients: The memorial sloan-kettering experience.
72:1986-90.
2001
-
Effect of sirolimus on the metabolism of apoB100-containing lipoproteins in renal transplant patients.
72:1244-50.
2001
-
Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection.
72:935-40.
2001
-
The influence of acute rejection on long-term renal allograft survival: A comparison of living and cadaveric donor transplantation.
72:69-76.
2001
-
Renal cell carcinoma detected in a cadaveric donor after orthotopic liver and contralateral renal transplantation in two recipients.
71:1348-9.
2001
-
The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients.
71:1303-7.
2001
-
Interleukin-2 and interferon-γ double knockout mice reject heterotopic cardiac allografts.
70:1378-81.
2000
-
Rapamycin induces transforming growth factor-β production by lymphocytes.
70:1104-6.
2000
-
Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.
70:656-61.
2000
-
Fas ligand-deficient gld mice are more susceptible to graft-versus-host- disease.
70:184-91.
2000
-
Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation.
70:202-5.
2000
-
Successful reuse of portal-enteric technique in pancreas retransplantation.
69:2443-5.
2000
-
A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.
69:1813-7.
2000
-
Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.
69:446-9.
2000
-
The influence of pulsatile preservation on renal transplantation in the 1990s.
69:249-58.
2000
-
Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function.
69:184-6.
2000
-
Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
69:49-54.
2000
-
Tuberculosis in orthotopic liver transplant patients: Increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.
69:64-9.
2000
-
Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant.
68:1846-50.
1999
-
Glucose control and long-term survival in biobreeding/worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression.
68:1693-700.
1999
-
The probability of HLA-C matching between patient and unrelated donor at the molecular level: Estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles.
68:1044-50.
1999
-
Perfusion of kidneys with unformulated 'naked' intercellular adhesion molecule-1 antisense oligodeoxynucleotide s prevents ischemic/reperfusion injury.
68:880-7.
1999
-
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.
68:307-9.
1999
-
The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.
67:1438-40.
1999
-
The United States liver donor population in the 1990s: A descriptive, population-based comparative study.
67:1019-23.
1999
-
A simple model to estimate survival after retransplantation of the liver.
67:422-30.
1999
-
Strategies to expand the donor pool for pancreas transplantation.
67:284-90.
1999
-
Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.
66:1387-8.
1998
-
Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
66:699-707.
1998
-
Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival.
66:426-34.
1998
-
Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: Conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15.
66:265-8.
1998
-
Mycobacterium tuberculosis infection of a native polycystic kidney following renal, transplantation.
66:118-20.
1998
-
A comparison of media supplement methods for the extended culture of human islet tissue.
65:1060-6.
1998
-
Liver transplantation for decompensated cirrhosis after jejunoileal bypass.
65:570-2.
1998
-
In vivo expression of transforming growth factor-β1 in humans: Stimulation by cyclosporine.
65:313-8.
1998
-
Utility of standardized histological classification in the management of acute rejection.
65:376-80.
1998
-
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: A southeastern organ procurement foundation multicenter clinical study.
65:87-92.
1998
-
Focal acute tubular necrosis in a renal allograft.
64:1490-2.
1997
-
Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model.
64:1102-7.
1997
-
In situ splitting of the cadaveric liver for transplantation.
64:871-7.
1997
-
In vivo hyperexpression of transforming growth factor-β1 in mice: Stimulation by cyclosporine.
63:1037-9.
1997
-
Anticardiolipin antibody-associated stroke after liver transplantation.
63:908-909.
1997
-
Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model.
63:528-32.
1997
-
Selective T cell receptor Vβ gene usage by alloreactive T cells responding to defined HLA-DR alleles.
62:1332-40.
1996
-
Blockade of multiple costimulatory receptors induces hyporesponsiveness: Inhibition or CD2 plus CD28 pathways.
62:1011-8.
1996
-
Induction of transplantation tolerance by chimeric donor/recipient class I RT1.A(A) molecules.
62:1002-10.
1996
-
Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: Influence of conditioning and hematopoietic reconstitution.
62:947-53.
1996
-
CD2 antigen targeting reduces intragraft expression of mRNA-encoding granzyme B and IL-10 and induces tolerance.
62:249-55.
1996
-
The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.
61:1711-5.
1996
-
Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole.
61:537-41.
1996
-
Long-term preservation of islets of Langerhans in hydrophilic macrobeads.
61:532-6.
1996
-
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.
61:492-7.
1996
-
Kidney-Pancreas transplantation: The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition.
60:1406-12.
1995
-
Mycobacterium haemophilum infections in bone marrow transplant recipients.
60:957-60.
1995
-
Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells.
60:82-9.
1995
-
Anti-CD2 monoclonal antibody-induced receptor changes: Down modulation of cell surface CD2.
59:1162-71.
1995
-
Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients.
59:1105-12.
1995
-
Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: Immunosuppression with TGF-β1 or vIL-10.
59:809-16.
1995
-
Abdominal multivisceral transplantation.
59:234-40.
1995
-
An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation.
59:1410-5.
1995
-
Membrane-bound or soluble truncated RT1.A<sup>a</sup> rat class I major histocompatibility antigens induce specific alloimmunity.
60:602-10.
1995
-
Pathogenesis of obliterative bronchiolitis. Possible roles of platelet- derived growth factor and basic fibroblast growth factor.
59:143-5.
1995
-
Renal allograft thrombosis associated with the antiphospholipid antibody syndrome.
60:614-5.
1995
-
Retrievable, replaceable, macroencapsulated pancreatic islet xenografts: Long-term engraftment without immunosuppression.
59:319-24.
1995
-
Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.
58:1014-20.
1994
-
Small intestinal transplantation in humans with or without the colon.
57:840-8.
1994
-
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
57:736-40.
1994
-
CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
58:1082-90.
1994
-
Clinical evaluation of induction immunosuppression with a murine IgG<inf>2b</inf>monoclonal antibody (BMA 031) directed toward the human α/β-T cell receptor.
57:1581-8.
1994
-
Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life.
57:816-22.
1994
-
Regulation of new DNA synthesis in mammalian cells by cyclosporine: Demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth.
57:577-82.
1994
-
Successful liver transplantation for isoniazid-induced hepatic failure - A case report.
57:1274-7.
1994
-
Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat ⍺/β-T cell receptor monoclonal antibody.
57:1544-8.
1994
-
The relationship of glucose disappearance rate (k<inf>g</inf>) to acute pancreas allograft rejection.
57:1400-5.
1994
-
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
55:901-8.
1993
-
Characterization of maturation and function of natural killer cells in xenogeneic (Rat → mouse) bone marrow chimeras: Evidence that rat NK cells are present and functional in a xenogeneic environment.
55:355-61.
1993
-
Effect of orthotopic liver transplantation and chemical denervation of the liver on the activities of hepatic monoamine oxidase and catechol-o-methyltransferase.
56:202-7.
1993
-
Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation: A potential strategy to avoid antibody induction protocols.
55:1008-13.
1993
-
Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.
55:947-9.
1993
-
Parvovirus B19 infection in pediatric transplant patients.
56:835-8.
1993
-
Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients.
56:609-12.
1993
-
Synergism between the CD3 antigen- and CD2 antigen-derived signals: Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine.
55:1118-24.
1993
-
The effect of donor-recipient strain combination on rejection and graft-versus-host disease after small bowel/liver transplantation in the rat.
56:381-5.
1993
-
The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
55:888-94.
1993
-
Cytomegalovirus infection of renal allografts: Detection by polymerase chain reaction.
53:99-102.
1992
-
Enisoprost in renal transplantation.
53:338-45.
1992
-
Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine.
53:146-51.
1992
-
Mixed xenogeneic chimeras (Rat + mouse to mouse) evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens.
53:815-22.
1992
-
The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation.
53:345-51.
1992
-
Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons.
52:960-6.
1991
-
Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
51:355-9.
1991
-
Effects of in vivo treatment with FK506 on natural killer cells in rats.
51:913-5.
1991
-
Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
51:636-41.
1991
-
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
51:378-81.
1991
-
Successful orthotopic liver transplantation in a child with langerhans cell histiocytosis.
51:278-80.
1991
-
The molecular basis for the synergism between the CD3/αβ T cell receptor and the CD2 antigen-derived signals in promoting T cell proliferation.
51:468-74.
1991
-
Characterization of the interstitial cellular infiltrate in experimental chronic cyclosporine nephropathy.
49:793-7.
1990
-
Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T-cell depleted haploidentical marrow.
50:55-61.
1990
-
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine.
49:191-4.
1990
-
Transbronchial biopsy.
49:1025.
1990
-
Lack of effect of oxygen-radical scavenging systems in the preserved reperfused rabbit kidney.
48:393-6.
1989
-
Selective depletion of kupffer cells in mice by intact ricin.
47:200-3.
1989
-
Transmembrane signalling via the T cell antigen receptor heterodimer and the CD2 antigen. A synergistic pathway for activation of T cells.
47:348-51.
1989
-
The effects of cooling rates and storage temperature on the function of 24-hour cold-preserved rabbit kidneys.
46:918-9.
1988
-
Chronic cyclosporine nephrotoxicity: A rodent model.
46:285-92.
1988
-
Human memory T cell activation. Effects of monoclonal antibodies directed at interleukin-2, receptors for interleukin-2, or interferon-γ.
46:292-8.
1988
-
In vivo effects of high-dose steroids on nucleic acid content of immunocompetent cells of renal allograft recipients.
45:534-6.
1988
-
Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo.
45:1118-23.
1988
-
Small bowel transplantation in the rat: Effect of pretransplant blood transfusions and cyclosporine on host survival.
45:1021-6.
1988
-
The effects of cooling rates and storage temperature on the function of 24-hour cold-preserved rabbit kidneys.
46:905-7.
1988
-
Urinary calculi in renal transplant recipients.
45:899-902.
1988
-
Use of anti-L3T4 and anti-Ia treatments for prolongation of xenogeneic islet transplants.
46:210-5.
1988
-
The effect of verapamil on cellular uptake, organ distribution, and pharmacology of cyclosporine.
44:395-401.
1987
-
Graft rejection in recipients of T-cell-depleted hla-nonidentical marrow transplants for leukemia: Identification of host-derived antidonor allocytotoxic T lymphocytes.
43:842-7.
1987
-
Okt3 treatment of steroid–resistant renal allograft rejection.
43:176-84.
1987
-
Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein.
41:593-7.
1986
-
Alterations in the generalized Schwartzman reaction induced by cyclosporine.
40:97-100.
1985
-
Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay.
40:317-22.
1985
-
A reappraisal of the effects of monoclonal antibodies directed at T cell differentiation antigens.
38:720-6.
1984
-
Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
38:501-6.
1984
-
Long-term renal allograft survival in rats preimmunized with donor strain RT1.B antigens.
35:289-93.
1983
-
Abrogation of proliferation and generation of cytotoxic T cells in human mixed lymphocyte culture reactions by modification of the cell surface with mitogenic oxidizing agents.
34:209-14.
1982
-
Enhanced kidney graft survival with retroplacental source γ-globulin: Results of a 5year prospective study at a single center.
33:636-41.
1982
-
Immunosuppressive properties of polar organic compounds that induce cellular differentiation in Friend erythroleukemia cells.
33:534-40.
1982
-
Impact of hepatitis on renal transplantation.
32:504-7.
1981
-
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
32:535-9.
1981
-
DR-Positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease.
30:331-4.
1980
-
Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.
30:269-74.
1980
-
Effects of protein-calorie restriction on the immune response to skin allografts in the rat.
30:219-25.
1980
-
Percutaneous transluminal dilation in renal transplant arterial stenosis.
30:440-4.
1980
-
Differential antibody responses to Ag B (A region) and Ia (B region) antigens during enhancement of rat renal allografts.
28:4-9.
1979
-
Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
27:333-7.
1979
-
Bone marrow transplantation using typing for glyoxalase i as a tool in histocompatibility testing.
28:156-8.
1979
-
Transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation.
28:359-61.
1979
-
Chimerism (505-507) by HL-A typing.
15:507-10.
1973
-
Failure of regional immunosuppressive therapy to modify renal allograft rejection..
6:554-6.
1968
-
Author's Reply: Ipsilateral Double Kidney Transplantation.
85:1508; author reply 1508-9.
2008
-
Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts (Transplantation (2007) 83, (1643)).
84:1375.
2007
-
Transplantation: A report of progress.
82:1557-791.
2006
-
Retraction..
79:1774.
2005
-
Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations.
79:1277-86.
2005
-
Systemic transforming growth factor-β1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
79:1091-6.
2005
-
Impact of sirolimus on early graft function after deceased-donor kidney transplantation [4] (multiple letters).
79:991; author reply 991-2.
2005
-
Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection [2].
79:736.
2005
-
The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.
78:904-10.
2004
-
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: Are they still appropriate?.
78:710-2.
2004
-
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine [10].
76:446.
2003
-
Allogeneic transplantation for advanced leukemia: Improved short-term outcome with blood stem cell grafts and tacrolimus.
62:1806-10.
1996
-
Molecular executors of cell death - Differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.
62:1860-6.
1996
-
Correlation between percutaneous renal biopsy and the indium-111-labeled platelet scan in diagnosing acute renal allograft rejection.
53:945-7.
1992
-
Percutaneous biopsy of pancreas transplants.
54:548-50.
1992
-
Successful reversal of hyperacute renal allograft rejection with the anti-CD3 monoclonal OKT.
54:930-2.
1992
-
Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.
53:224-5.
1992
-
Combined small bowel and liver transplantation in the rat: Possible role of the liver in preventing intestinal allograft rejection.
52:550-2.
1991
-
Lung biopsy evaluation of acute rejection versus opportunistic infection in lung transplant patients.
47:713-5.
1989
-
Postpartum renal failure in a renal transplant patient.
47:717-9.
1989
-
Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
45:810-3.
1988
-
HLA-A2 in sarcomas: An immunobiologic perspective.
43:923-5.
1987
-
Low-dose immunosuppressive therapy in kidney transplantation.
34:232-3.
1982
-
Trypsinization of lymphocytes for HL-A typing.
13:192-4.
1972
-
Taking stock and moving forward
2003
-
New tricks for leukocytes: Memory where you least suspect it.
99:2007-8.
2015
-
The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation..
95:15-6.
2013
-
Transplantation: A report of progress.
90:1245.
2010
-
The significance of non-T-cell pathways in graft rejection: Implications for transplant tolerance.
90:1043-7.
2010
-
Transplantation: A report of progress.
86:1635.
2008
-
Welcome to a new transplantation journal!: Editorial.
70:559.
2000
-
A new year and a new look.
67:1.
1999
-
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy
2013
-
High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection
2013
-
On the detection of anti-HLA antibodies using single antigen bead luminex assay: Lot-to-lot variations in MFI
2013
-
Authors' reply: Expanding the donor pool: Optimal utilization of pediatric donor kidneys
2011
-
Malakoplakia-induced diarrhea in a kidney transplant recipient
2010
-
Sirolimus (rapamycin) induced proteinuria in a patient undergoing allogeneic hematopoietic stem cell transplant.
2008
-
The emerging role of nanotechnology in cell and organ transplantation
2016
-
Pericytes, microvasular dysfunction, and chronic rejection
2015
-
The evolving roles of memory immune cells in transplantation
2015
-
MicroRNAs: Small RNAs with big effects
2010
-
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns
2008
-
STAT3: An important regulator of multiple cytokine functions
2008
-
The role of mast cells after solid organ transplantation
2008
-
Why nondocumented residents should have access to kidney transplantation: Arguments for lifting the federal ban on reimbursement
2007
-
Primary intestinal posttransplant T-cell lymphoma
2003
-
Tolerance and chimerism
2003
-
FK506-associated thrombotic microangiopathy: Report of two cases and review of the literature
1999
-
Financial and social complications as barriers to satisfaction with life among living kidney donors
2014
-
Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease
2009
-
Noninvasive imaging of living kidney donors
2008
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)